IART Q3 2023 Earnings — Integra LifeSciences Holdings Corporation Revenue & Financial Results | Market Cap Arena

IARTIntegra LifeSciences Holdings Corporation

$738M

Q3 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$382M-0.7% YoY

Gross Profit

$218M57.1% margin

Operating Income

$27M7.0% margin

Net Income

$19M5.1% margin

EPS (Diluted)

$0.24

QoQ Revenue Growth

+0.3%

Cash Flow

Operating Cash Flow

$27M

Free Cash Flow

$14M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$3.7B

Total Liabilities

$2.2B

Stockholders' Equity

$1.6B

Cash & Equivalents

$274M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$382M	$385M	-0.7%
Gross Profit	$218M	$237M	-7.8%
Operating Income	$27M	$65M	-59.1%
Net Income	$19M	$50M	-60.9%

Revenue Segments

Codman Specialty Surgical

$268M70%

Tissue Technologies

$114M30%

Geographic Segments

UNITED STATES

$270M71%

Asia Pacific

$49M13%

Europe

$42M11%

Rest Of World

$22M6%